Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions
Endoscopy International Open · 2024-03 · 12 (03) · E448-E455
DOI: 10.1055/a-2246-0820 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy International Open, online erschienen am 28.03.2024. Verfasst von Daisuke Ohki und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims This study aimed to evaluate the relationship between sessile serrated lesion (SSL) size and the comorbidity rate of SSL with dysplasia (SSLD) and cancer in SSL (SSL-cancer). Patients and methods This retrospective, single-center analysis identified SSL cases that underwent endoscopic resection between January 2015 and December 2022. The prevalence of SSL, SSLD, and SSL-cancer and their annual trends were assessed. The tumor diameter was stratified as 0 to 5 mm, 6 to 9 mm, 10 to 19 mm, and ≥ 20 mm in size. Furthermore, the frequency of SSL-D/SSL-cancer was determined in each group.
Results
The prevalence of SSL was 2.9% (1328/45799). This prevalence was 1.8% (112/6192) in 2015 and 4.2% (230/5500) in 2022, indicating an increasing trend over time. A total of 1825 lesions were assessed: 1751 (96.0%), 55 (3.0%), 14 (0.8%), and 5 (0.3%) of lesions were SSL, SSL with low-grade dysplasia, SSL with high-grade dysplasia and SSL-cancer, respectively. Stratifying the SSLs by size: 0 to 5 mm, 5 to 9 mm, 10 to 19 mm, and ≥ 20 mm, SSLD and SSL-cancer rates were 2.3% (10/429), 2.4% (16/674), 5.3% (31/584), and 11.8% (16/136), respectively. SSLD and SSL-cancer were observed in 2.4% (26/1103) of small SSLs < 10 mm.
Conclusions
In cases of SSL, the rate of SSLD and SSL-cancer increased as the lesion diameter increased. A certain rate of SSLD and SSL-cancer was observed even in small SSLs less than 5mm.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
- Next-Generation Endoscopic Computer Vision, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.
- Department of Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
ORCID-Profile: Daisuke Ohki, Mitsuhiro Fujishiro
Zitieren
APA
Ohki, D., Tsuji, Y., Hisada, H., Nakagawa, H., Mizutani, S., Oshio, K., Sato, J., Kubota, D., Cho, R., Miura, Y., Mizutani, H., Sakaguchi, Y., Takahashi, Y., Yakabi, S., Kakushima, N., Yamamichi, N., Ushiku, T., & Fujishiro, M. (2024). Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions. Endoscopy International Open, 12(03), E448-E455. https://doi.org/10.1055/a-2246-0820
Vancouver
Ohki D, Tsuji Y, Hisada H, Nakagawa H, Mizutani S, Oshio K, et al. Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions. Endoscopy International Open. 2024;12(03):E448-E455. doi:10.1055/a-2246-0820
BibTeX
@article{Ohki2024,
author = {Ohki, Daisuke and Tsuji, Yosuke and Hisada, Hiroyuki and Nakagawa, Hideki and Mizutani, Satoru and Oshio, Kaori and Sato, Junichi and Kubota, Dai and Cho, Rina and Miura, Yuko and Mizutani, Hiroya and Sakaguchi, Yoshiki and Takahashi, Yu and Yakabi, Seiichi and Kakushima, Naomi and Yamamichi, Nobutake and Ushiku, Tetsuo and Fujishiro, Mitsuhiro},
title = {Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions},
journal = {Endoscopy International Open},
year = {2024},
volume = {12},
number = {03},
pages = {E448--E455},
doi = {10.1055/a-2246-0820}
}
EUVIMED